[Construction and Eukaryotic Expression of Recombinant Plasmid Encoding Fusion Protein of Goat Complement C3d and Foot-and-mouth Disease Virus VP1].

Jieyu Ling,Zhao Liu,Tiezhu Tong,Huiying Fan,Dekun Zhang,Huanchun Chen,Aizhen Guo
DOI: https://doi.org/10.1016/s1872-2075(08)60012-6
2008-01-01
Abstract:We constructed a recombinant plasmid encoding VP1 gene of O type foot-and-mouth disease virus fused to a molecular adjuvant, goat complement C3d gene. The goat C3d gene was cloned and three copies were tandem-linked with the linker (G4S)2 sequence. VP1 gene of O type foot-and-mouth disease virus was linked to three tandem repeats of C3d through the linker sequence and cloned into pUC19 to obtain the recombinant plasmid pUC19-VP1-C3d3. The VP1-C3d3 fusion gene was then subcloned into the eukaryotic vector pcDNA3.1(+) that had been modified to contain the tissue plasminogen activator (tPA) leader sequence to obtain pcDNA3.1-tPA-VP1-C3d3. HeLa cells were transfected with pcDNA3.1-tPA-VP1-C3d3 by Lipofectamine™ 2000. Indirect immunofluorescent assay and Western blot assay showed that VP1-C3d3 fusion gene was successfully expressed in HeLa cells. The fusion protein with the expected size 133 kD could be secreted outside the cells. This study lays good foundation for further research on the novel vaccine against the foot-and-mouth disease virus using goat C3d as a molecular adjuvant to enhance the immunogenicity of VP1.
What problem does this paper attempt to address?